share_log

Alibaba Health Information Technology (OTC:ALBHF) Stock Price Down 2.2%

Defense World ·  Dec 28, 2022 01:31

Alibaba Health Information Technology Limited (OTC:ALBHF – Get Rating) dropped 2.2% on Tuesday . The stock traded as low as $0.90 and last traded at $0.90. Approximately 5,010 shares changed hands during trading, a decline of 96% from the average daily volume of 115,639 shares. The stock had previously closed at $0.92.

Alibaba Health Information Technology Stock Performance

The company has a 50-day moving average of $0.73 and a two-hundred day moving average of $0.63.

Alibaba Health Information Technology Company Profile

(Get Rating)

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. It offers range of prescription drugs, over-the-counter drugs, nutritional supplements, medical devices, contact lenses, and various other health-related products through its online stores on Tmall.com and offline pharmacy outlets to business-to-customer and business-to-business customers; and pharmaceutical products, medical devices and healthcare products, health food, sexual health and family planning products, contact lenses, and medical and healthcare services through its e-commerce platform.

Featured Stories

  • Get a free copy of the StockNews.com research report on Alibaba Health Information Technology (ALBHF)
  • 3 Industrial Stocks to Help Build Your 2023 Watchlist
  • The Institutions Choose CarMax Over Carvana, Should You?
  • Heatmap in Trading: How to Learn What Market Depth Hides
  • Micron Technology Sees Chip Recovery by the End of 2023
  • Three Healthcare Penny Stocks to Watch In The New Year

Receive News & Ratings for Alibaba Health Information Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alibaba Health Information Technology and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment